4//SEC Filing
Azelby Robert 4
Accession 0001104659-20-117802
CIK 0000722830other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 5:34 PM ET
Size
9.5 KB
Accession
0001104659-20-117802
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
Azelby Robert
Director
Transactions
- Disposition to Issuer
Restricted Stock Unit
2020-10-23−3,718→ 0 total→ Common Stock (3,718 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-23−29,040→ 0 total→ Common Stock (29,040 underlying)
Footnotes (2)
- [F1]In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock ("Stock Option") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration.
- [F2]In connection with the consummation of the Merger, at the Effective Time, each restricted stock unit to acquire shares of Common Stock ("Restricted Stock Unit") that was outstanding as of immediately prior to the Effective Time, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash equal to (A) the Offer Price, multiplied by (B) the total number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time.
Documents
Issuer
IMMUNOMEDICS INC
CIK 0000722830
Entity typeother
Related Parties
1- filerCIK 0001656998
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 5:34 PM ET
- Size
- 9.5 KB